Mind Medicine (MNMD) announced the appointment of Gregg Pratt as chief regulatory and quality assurance officer. Pratt will serve as a member of the executive committee and oversee the company’s regulatory and quality functions, as well as its product registration strategies. Pratt joins MindMed from Karuna Therapeutics.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter